<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Merck &amp; Co., Inc. - Google Finance</title>
<description>News for Merck &amp; Co., Inc. - Google Finance</description>
<link>http://www.google.com/finance?q=NYSE:MRK&amp;amp;client=news-rss&amp;amp;ei=b0eYUbD-JPK40QHVhAE</link>
<image>
<title>News for Merck &amp; Co., Inc. - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NYSE:MRK&amp;amp;client=news-rss&amp;amp;ei=b0eYUbD-JPK40QHVhAE</link>
</image>
<item>
<title>MERCK &amp;amp; CO., INC. : Merck to Present at the UBS Global Healthcare Conference</title>
<link>http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-to-Present-at-the-UBS-Global-Healthcare-Conference-16870629/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982062407031</guid>
<pubDate>Fri, 17 May 2013 19:52:50 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-to-Present-at-the-UBS-Global-Healthcare-Conference-16870629/&quot; style=&quot;font-size:1.2em&quot;&gt;MERCK &amp;amp; CO., INC. : Merck to Present at the UBS Global Healthcare Conference&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the UBS Global Healthcare Conference in New York City ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Citigroup Inc (C), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; Investing In The Future</title>
<link>http://www.insidermonkey.com/blog/citigroup-inc-c-merck-co-inc-mrk-investing-in-the-future-139823/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/citigroup-inc-c-merck-co-inc-mrk-investing-in-the-future-139823/</guid>
<pubDate>Mon, 13 May 2013 01:06:05 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/citigroup-inc-c-merck-co-inc-mrk-investing-in-the-future-139823/&quot; style=&quot;font-size:1.2em&quot;&gt;Citigroup Inc (C), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; Investing In The Future&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Citigroup Inc (NYSE:C) In the world of investing, the amount of data to factor into the purchase of a stock can be overwhelming.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Johnson &amp;amp; Johnson (JNJ), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; What To Watch</title>
<link>http://www.insidermonkey.com/blog/johnson-johnson-jnj-merck-co-inc-mrk-what-to-watch-141287/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060715080</guid>
<pubDate>Tue, 14 May 2013 16:51:40 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/johnson-johnson-jnj-merck-co-inc-mrk-what-to-watch-141287/&quot; style=&quot;font-size:1.2em&quot;&gt;Johnson &amp;amp; Johnson (JNJ), Merck &amp;amp; Co., Inc. (MRK) &amp;amp; What To Watch&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Johnson &amp;amp; Johnson (NYSE:JNJ) Pharmaceutical companies in the U.S. are not having it easy these days. When Johnson &amp;amp; Johnson (NYSE:JNJ) reported its latest numbers recently, it suffered from currency headwinds.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>MERCK &amp;amp; CO., INC. : Merck Prices $ 6.5 Billion Debt Offering</title>
<link>http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-Prices-$-6-5-Billion-Debt-Offering-16865397/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982062983016</guid>
<pubDate>Wed, 15 May 2013 22:31:29 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/MERCK-CO-INC-13611/news/Merck-Co-Inc-Merck-Prices-$-6-5-Billion-Debt-Offering-16865397/&quot; style=&quot;font-size:1.2em&quot;&gt;MERCK &amp;amp; CO., INC. : Merck Prices $ 6.5 Billion Debt Offering&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. : Merck Prices $ 6.5 Billion Debt Offering. 05/15/2013| 06:30pm US/Eastern. Recommend: 0. Merck &amp;amp; Co., Inc. priced today a $6.5 billion public offering of senior unsecured notes. The notes include: $1,000 million of 0.70% notes due ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. (MRK): Big Payout, Little Flexibility</title>
<link>http://www.insidermonkey.com/blog/merck-co-inc-mrk-big-payout-little-flexibility-139934/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.insidermonkey.com/blog/merck-co-inc-mrk-big-payout-little-flexibility-139934/</guid>
<pubDate>Mon, 13 May 2013 13:45:20 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/merck-co-inc-mrk-big-payout-little-flexibility-139934/&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. (MRK): Big Payout, Little Flexibility&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Merck &amp;amp; Co., Inc. (NYSE:MRK) Big pharma isn&amp;#39;t the first industry many investors envision when dreaming of the big profits to be made from health care stocks.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>DOW LAGGARDS: AT&amp;amp;T Inc, Merck &amp;amp; Co., Inc., Pfizer Inc., Wal-Mart Stores Inc.</title>
<link>http://www.sbwire.com/press-releases/dow-laggards-att-inc-merck-co-inc-pfizer-inc-wal-mart-stores-inc-253433.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982064488555</guid>
<pubDate>Fri, 17 May 2013 16:09:11 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/dow-laggards-att-inc-merck-co-inc-pfizer-inc-wal-mart-stores-inc-253433.htm&quot; style=&quot;font-size:1.2em&quot;&gt;DOW LAGGARDS: AT&amp;amp;T Inc, Merck &amp;amp; Co., Inc., Pfizer Inc., Wal-Mart Stores Inc.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Huntington Beach, CA -- (SBWIRE) -- 05/17/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks traded on the NASDAQ, ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Volume In Focus: DryShips Inc. (NASDAQ:DRYS), Merck &amp;amp; Co., Inc.(NYSE:MRK ...</title>
<link>http://www.cogonews.com/drys-volume-in-focus-dryships-inc-nasdaqdrys-merck-co-inc-nysemrk-barrick-gold-corporation-usa-nyseabx/126471/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982063423853</guid>
<pubDate>Fri, 17 May 2013 16:01:27 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.cogonews.com/drys-volume-in-focus-dryships-inc-nasdaqdrys-merck-co-inc-nysemrk-barrick-gold-corporation-usa-nyseabx/126471/&quot; style=&quot;font-size:1.2em&quot;&gt;Volume In Focus: DryShips Inc. (NASDAQ:DRYS), Merck &amp;amp; Co., Inc.(NYSE:MRK ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Cogo&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;DryShips Inc. (NASDAQ:DRYS) shares decreased 1.90% to $2.06. Global Hunter Securities initiated coverage on shares of DRYS in a research note issued on April 17.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Pfizer Inc. (PFE) and Merck &amp;amp; Co., Inc. (MRK) News: Expectations Of What&amp;#39;s ...</title>
<link>http://www.insidermonkey.com/blog/pfizer-inc-pfe-and-merck-co-inc-mrk-news-expectations-of-whats-next-gettin-bond-y-more-144517/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982064331624</guid>
<pubDate>Fri, 17 May 2013 19:30:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/pfizer-inc-pfe-and-merck-co-inc-mrk-news-expectations-of-whats-next-gettin-bond-y-more-144517/&quot; style=&quot;font-size:1.2em&quot;&gt;Pfizer Inc. (PFE) and Merck &amp;amp; Co., Inc. (MRK) News: Expectations Of What&amp;#39;s ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 17, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Editor&amp;#39;s Note: Pfizer Inc. (NYSE:PFE), Merck &amp;amp; Co., Inc. (NYSE:MRK), Petroleo Brasileiro Petrobras SA (NYSE:PBR), American Express Company (NYSE:AXP).&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to ...</title>
<link>http://www.marketwatch.com/story/merck-co-inc-and-pfizer-enter-worldwide-collaboration-agreement-to-develop-and-commercialize-ertugliflozin-an-investigational-medicine-for-type-2-diabetes-2013-04-29</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778137850432</guid>
<pubDate>Mon, 29 Apr 2013 11:30:48 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/merck-co-inc-and-pfizer-enter-worldwide-collaboration-agreement-to-develop-and-commercialize-ertugliflozin-an-investigational-medicine-for-type-2-diabetes-2013-04-29&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;MarketWatch (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;WHITEHOUSE STATION, N.J. &amp;amp; NEW YORK, Apr 29, 2013 (BUSINESS WIRE) -- Merck &amp;amp; Co., Inc. (NYSE:MRK) , known as MSD outside the United States and Canada (&amp;quot;Merck&amp;quot;), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a ...&lt;/div&gt;
&lt;a href=&quot;http://www.businessweek.com/ap/2013-04-29/earnings-preview-merck-to-key-on-coming-new-drugs&quot;&gt;Earnings Preview: Merck to key on coming new drugs&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Businessweek&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Merck &amp;amp; Co., (MRK) guaranteed senior unsec. rating to A1 from Aa3 by Moody&amp;#39;s</title>
<link>http://www.streetinsider.com/Credit+Ratings/Merck+%26+Co.,+(MRK)+guaranteed+senior+unsec.+rating+to+A1+from+Aa3+by+Moodys/8338323.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982059673503</guid>
<pubDate>Tue, 14 May 2013 21:40:56 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.streetinsider.com/Credit+Ratings/Merck+%26+Co.,+(MRK)+guaranteed+senior+unsec.+rating+to+A1+from+Aa3+by+Moodys/8338323.html&quot; style=&quot;font-size:1.2em&quot;&gt;Merck &amp;amp; Co., (MRK) guaranteed senior unsec. rating to A1 from Aa3 by Moody&amp;#39;s&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;StreetInsider.com (subscription)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Trade MRK Now! Moody&amp;#39;s Investors Service placed the long-term senior unsecured ratings of Merck &amp;amp; Co., Inc. (&amp;quot;Merck&amp;quot;) under review for downgrade.&lt;/div&gt;
&lt;a href=&quot;http://www.moodys.com/research/Moodys-rates-Mercks-new-non-guaranteed-debt-A2-stable-outlook--PR_273187&quot;&gt;Moody&amp;#39;s rates Merck&amp;#39;s new non-guaranteed debt A2; stable outlook&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Moodys.com (press release) (registration)&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.marketwatch.com/story/moodys-cuts-merck-credit-rating-noting-buybacks-2013-05-14&quot;&gt;Moody&amp;#39;s cuts Merck credit rating, noting buybacks&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;MarketWatch&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
